Greater Manchester has a deep heritage in science, innovation and entrepreneurship.
The NIHR Manchester Biomedical Research Centre (BRC) connects world-leading researchers based at The University of Manchester and three NHS Trusts in Greater Manchester, with a vision to drive health improvements and lasting change for all through creative, inclusive and proactive research that identifies and bridges gaps between new discoveries and individualised care.
Read moreAn international team of scientists, including Manchester BRC researcher Dr Hannah Durrington has found that shift workers, especially those working permanent night shifts, showed increased risks of asthma, especially moderate or severe asthma.
Manchester research means women diagnosed with womb cancer should now be routinely screened for the genetic condition Lynch syndrome (LS), following a new guideline issued by the National Institute for Health and Care Excellence (NICE).
Professor Paul Dark, Non-fungal Infections Programme Lead and researchers from a leading NIHR study are investigating how to improve the use of antibiotics for patients with COVID-19 at risk of sepsis.
We are driving forward pioneering research into new tests and treatments in musculoskeletal disease, hearing health, respiratory disease, dermatology and three cancer themes (prevention, radiotherapy and precision medicine), utilising our expertise in biomarkers, informatics and the rapid translation of research findings.
There are plently of opportunities for people to help shape our research plans. Research is vital to help us understand more about a particular disease or condition and how to treat them.
Read more